Mediera Corporation (TPEX:5398)
Taiwan · Delayed Price · Currency is TWD 13.85
-0.05 (-0.36%)
Sep 30, 2026, 1:30 PM CST
Mediera Market Cap
Mediera has a market cap or net worth of 687.56 million as of September 29, 2026. Its market cap has decreased by -30.85% in one year.
Market Cap
687.56M
Enterprise Value
514.49M
Revenue
195.89M
Ranking
n/a
PE Ratio
141.13
Stock Price
13.85
ChartMarket Cap Chart
Since November 3, 2004, Mediera's market cap has increased from 257.38M to 687.56M, an increase of 167.14%. That is a compound annual growth rate of 4.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 687.56M | -46.54% |
| Dec 31, 2025 | 1.29B | 33.67% |
| Dec 31, 2024 | 962.10M | 27.54% |
| Dec 29, 2023 | 754.35M | -7.01% |
| Dec 30, 2022 | 811.23M | -19.01% |
| Dec 30, 2021 | 1.00B | 4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.94B |
| InnoPharmax | 1.28B |
| GeneFerm Biotechnology | 1.19B |
| Excelsior Biopharma | 1.09B |
| Anxo Pharmaceutical | 1.07B |
| Prince Pharmaceutical | 1.07B |
| DV Biomed | 989.79M |
| Original BioMedicals | 828.42M |